Study shows the impact of socioeconomic development on global cancer burden

Cancer remains a significant public health challenge, with the GLOBOCAN 2020 report estimating a staggering 19.3 million new cancer cases and 10 million cancer-related deaths globally.

MorphoSys Enters into Business Combination Agreement to be Acquired by Novartis for € 2.7 Billion Equity Value – Biotech Investments

EQS-News: MorphoSys AG / Key word(s): Mergers & Acquisitions/Disposal MorphoSys Enters into Business Combination Agreement to be Acquired by Novartis for € 2.7 Billion Equity

February 6, 2024

Patent Filed for Treating Cancer with Immune Checkpoint Inhibitor

According to GlobalData’s company profile on Cue Biopharma, CAR-T cell based therapies was a key innovation area identified from patents. Cue Biopharma‘s grant share as

June 10, 2024

Gilead’s rare liver disease drug improves symptoms in another Phase 3 study ahead of FDA decision

Gilead reported more positive data over the weekend from its rare liver disease drug candidate seladelpar, which it got when it snapped up CymaBay for

May 21, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.